Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05  •  04:00PM ET
28.35
Dollar change
-0.19
Percentage change
-0.65
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y7.79% Total Holdings70 Perf Week-1.68%
SponsorFidelity ETF Type Tagsequity Return% 3Y- AUM62.68M Perf Month9.56%
Fund Family Bond Type Tagstechnology Return% 5Y- NAV/sh Perf Quarter12.75%
Index- Average Maturity Tagsmedical Return% 10Y 52W High29.07 -2.49% Perf Half Y17.39%
Index Weighting Commodity Type Tagsdisruptive Return% SI 52W Low20.69 37.02% Perf YTD14.96%
Active/Passive Quant Type Tagsinnovation Flows% 1M0.00% Volatility1.04% 1.27% Perf Year7.79%
Dividend TTM0.11 (0.40%) ESG Type Tags- Flows% 3M0.00% ATR (14)0.37 Perf 3Y-
Dividend Ex-DateDec 20, 2024 Dividend Type Sector/Theme Flows% YTD3.92% RSI (14)62.81 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.98 Perf 10Y-
Expense0.50% Growth/Value SMA202.47% Flows% 3Y Rel Volume1.61 Prev Close28.53
Inverse/Leveraged Market Cap SMA506.55% Flows% 5Y Avg Volume5.74K Price28.35
IPOJun 12, 2023 Option/ShortNo / Yes SMA20015.43% Trades Volume9,260 Change-0.65%
Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.